synthetic human papillomavirus 16 E6 peptide

BIOLOGICAL2 trials

Sponsors

European Organisation for Research and Treatment of Cancer - EORTC, National Cancer Institute (NCI)

Conditions

Anal CancerCervical CancerEsophageal CancerHead and Neck CancerPenile CancerVulvar Cancer

Phase 1

Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer

CompletedNCT00019110

National Cancer Institute (NCI)Anal Cancer, Cervical Cancer, Esophageal Cancer +3

Start: 1995-11-30Updated: 2015-04-29

Phase 2

Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer

CompletedNCT00002916

European Organisation for Research and Treatment of Cancer - EORTCCervical Cancer

Start: 1996-11-30Target: 44Updated: 2012-07-02

Related Papers

Results disclosure of papilloma vaccine studies in humans completed before January 1st, 2011.

Figshare2014-01-01

Results disclosure of papilloma vaccine studies in humans co.

Figshare2014-01-01